LB is a clinical stage CNS-focused life science company devoted to commercializing novel and improved versions of successful CNS treatments used extensively overseas but never approved in the United States. LB-102, or N-methyl amisulpride, is the Company's lead clinical asset. LB was founded in 2015 and is based in New York City.
View Top Employees from LB Pharmaceuticals| Website | http://lbpharma.us |
| Revenue | $4 million |
| Funding | $10 million |
| Employees | 3 (3 on RocketReach) |
| Founded | 2015 |
| Address | 575 Madison Ave, New York City, New York 10022, US |
| Phone | (917) 450-6581 |
| Industry | Drug Stores & Pharmacies, Biopharma, Retail, Biotechnology, Health Care, Science and Engineering, Pharmaceutical |
| SIC | SIC Code 283 Companies, SIC Code 28 Companies |
| NAICS | NAICS Code 32 Companies, NAICS Code 3254 Companies, NAICS Code 325 Companies, NAICS Code 32541 Companies |
Looking for a particular LB Pharmaceuticals employee's phone or email?
LB Pharmaceuticals Questions
The LB Pharmaceuticals annual revenue was $4 million in 2024.
Andrew Vaino is the Chief Scientific Officer of LB Pharmaceuticals.
3 people are employed at LB Pharmaceuticals.
LB Pharmaceuticals is based in New York City, New York.
The NAICS codes for LB Pharmaceuticals are [32, 3254, 325, 32541].
The SIC codes for LB Pharmaceuticals are [283, 28].
Top LB Pharmaceuticals Employees
-
25+
-
35
